Dear All
I came across this announcement by Mark Arnold in AAPS Community and thought of spreading the news here as well.
From the e-mail announcement:
"Today, after several months of collaboration, the FDA and the European Medicines Agency (EMA) are releasing a common set of 10 guiding principles to inform, enhance, and promote the use of artificial intelligence (AI) for generating evidence across all phases of the drug product life cycle.
The integration of AI in drug development has the potential to transform the way drugs are developed and evaluated, ultimately improving health care. AI technologies are anticipated to help promote innovation, reduce time-to-market, strengthen regulatory excellence and pharmacovigilance, and decrease reliance on animal testing by improving the prediction of toxicity and efficacy in humans."
https://www.fda.gov/about-fda/artificial-intelligence-drug-development/guiding-principles-good-ai-practice-drug-development?utm_medium=email&utm_source=govdelivery
#fda #EMA #AI #Principles
------------------------------
Dedeepya Pasupuleti
Assistant Professor
Larkin University
Miami FL
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------